ITGI Medical

ITGI Medical developed and commercialized proprietary medical devices, primarily focusing on covered stent technologies for use in interventional cardiology. Its main product line included pericardium-covered stents designed to treat coronary artery perforations and saphenous vein graft lesions. The company’s products received CE Mark approval and were distributed internationally. There are no recent clinical results due to the company's inactive status. ITGI Medical was an Israeli-based medtech company specializing in innovative cardiovascular devices—most notably a proprietary pericardium-covered coronary stent used by interventional cardiologists. The firm achieved regulatory milestones such as CE Marking and had some international market presence but ultimately became inactive without being acquired by another entity. It played a role within Israel's vibrant early-stage life science sector through both product development and leadership talent that later moved into other companies within the field.